Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 6


Authors Rapidis A, Sarlis N, Lefebvre J, Kies M

Published 5 December 2008 Volume 2008:4(6) Pages 1381—1381


Rapidis A, Sarlis N, Lefebvre J-L, et al. 2008. Docetaxel in the treatment of squamous cell carcinoma of the head and neck. Ther Clin Risk Manag, 4:865–886

Page 870, right column of text: TPF and PF were given for 3 cycles not 4 cycles.

Page 871, Table 2 caption should read: TAX 323: select efficacy and safety results.

Page 872, Table 3 caption should read: TAX 324: select efficacy and safety results.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]